This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

68 results

Lamictal Tablets

Lamotrigine<br>CNS

Product Overview

Information for health professionals about Lamictal (lamotrigine) for the treatment of epilepsy, provided by GSK.

Safety information

Information for health professionals about Lamictal (lamotrigine) for the treatment of epilepsy, provided by GSK.

Lamictal

Lamotrigine</br> Neurology

Clinical evidence

Clinical evidence: efficacy of Lamictal (lamotrigine) in attaining seizure freedom and maintaining seizure control with good tolerability.

Resources

A comprehensive list of resources to support patients with epilepsy who have been prescribed Lamictal (lamotrigine).

Flixonase Nasal Spray

Fluticasone-propionate<br>Respiratory

Product Summary

Relvar Ellipta product information – including outline of key benefits in asthma and COPD and an introduction to Relvar mode of action

Uncovering patient symptoms

How well-controlled is asthma in your patients? Emerging evidence suggests that people may not always report symptoms to their physician, perhaps because they have learned to live with them.

Relvar Ellipta (fluticasone furoate/vilanterol)

Fluticasone furoate/vilanterol</br> Respiratory

Avamys

fluticasone furoate<br>Respiratory

Ventolin Inhaler

salbutamol <br>Respiratory

Eumovate

Clobetasone butyrate <br>Dermatology

Guidelines

Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children

Dosage & device

Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video

Avamys

fluticasone furoate<br>Allergy

Safety

Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate

Efficacy

Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video

Indication

Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient

Product Listing Page

Providing healthcare professionals with timely, relevant information on GSK products and related therapy areas, events and educational opportunities, including information from experts, journals and news to enrich your clinical practice.

Dosage and Administration

Information about Zinnat dosage and administration and links to support Kenyan Health Care Professionals in their daily practice

Efficacy

Information about Zinnat efficacy and links to support Kenyan Health Care Professionals in their daily practice.

Zinnat

Zinnat product information and links to support Kenya Health Care Professionals in their daily practice<br> Anti-infectives

Safety

Zinnat cefuroxime product information and links to support Kenyan Health Care Professionals in their daily practice

About Zinnat

Information about Zinnat and links to support Kenyan Health Care Professionals in their daily practice

Indications

Information about Zinnat and links to support Kenyan Health Care Professionals in their daily practice

Resources

Zinnat product information and links to support Kenya Health Care Professionals in their daily practice

Safety & Efficacy

DUODART treats and prevents progression of benign prostatic hyperplasia (BPH) through alleviating symptoms, reducing prostate size (volume), improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH related surgery.

Duodart

Dutasteride-tamsulosin hydrochloride</br> Urology

Dosing

One capsule, one dose, once daily – Duodart is a simple solution, with only a single once-a-day capsule required.

About Duodart

DUODART treats and prevents progression of benign prostatic hyperplasia (BPH) through alleviating symptoms, reducing prostate size (volume), improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH related surgery.

Clinical evidence

DUODART treats and prevents progression of benign prostatic hyperplasia (BPH) through alleviating symptoms, reducing prostate size (volume), improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH related surgery.

Tivicay

Dolutegravir<br>HIV

Drug – Drug Interactions

TRIUMEQ a well-characterised and easy-to-manage DDI profile

Safety & Tolerability

Dolutegravir the core agent in TRIUMEQ has a favourable safety and tolerability profile with few discontinuations due to AEs in treatment-naïve trials

DTG – Related Studies

Extensive clinical development programme, dolutegravir—the core agent in TRIUMEQ—has demonstrated superiority in 5 Phase III clinical trials and continues to be evaluated in combination ART

Indication and Dosing

Once-Daily TRIUMEQ Makes Dosing and Administration Simple for Your Patients

Triumeq

Dolutegravir/abacavir/lamivudine</br> HIV

Clinical data

Clinical data and real-world experience demonstrate the high barrier to resistance of dolutegravir—the core agent in TRIUMEQ

Bactroban Cream

mupirocin calcium<br>Dermatology

Betnovate Cream & Ointment

betamethasone 17-valerate<br>Dermatology

Zyrtec

cetirizine<br>respiratory

Seretide (salmeterol/fluticasone propionate)

Salmeterol/Fluticasone Propionate<br> Respiratory

Synflorix

Pneumococcal polysaccharide</br> Vaccines

Dosage & Administration

Information for health professionals about the dosing and administration of Keppra (levetiracetam) for the treatment of epilepsy.

Product Overview

Information for health professionals about Keppra (levetiracetam) for the treatment of epilepsy, provided by GSK.

Safety information

Information for health professionals about the safety profile of Keppra (levetiracetam) for the treatment of epilepsy.

Keppra

Levetiracetam</br> Neurology

Clinical evidence

Clinical evidence: efficacy of Keppra (levetiracetam) in attaining seizure freedom and maintaining seizure control in different patient populations.

Resources

A comprehensive list of resources to support patients with epilepsy who have been prescribed Keppra (levetiracetam).

Dosage and Administration

Augmentin (amoxicillin-clavulanate) dosage and administration information designed to help healthcare professionals in their daily practice

Augmentin

amoxicillin-clavulanate</br> Anti-infectives

Safety

Information regarding the safety and tolerability of Augmentin (amoxicillin- clavulanate).

Augmentin Patient Resources

A comprehensive list of resources to support patients who have been prescribed Augmentin (amoxicillin-clavulanate)

Indication

Augmentin (amoxicillin-clavulanate) is indicated for a wide range of infections. This comprehensive information is designed to help healthcare professionals in daily practice

Flixotide

fluticasone propionate</br> Respiratory

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

show more